Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients
Top Cited Papers
Open Access
- 1 August 2017
- journal article
- research article
- Published by Informa UK Limited in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 12, 2465-2475
- https://doi.org/10.2147/copd.s141295
Abstract
Introduction: A low body mass index (BMI) is associated with increased mortality and low health-related quality of life in patients with COPD. The Asia-Pacific classification of BMI has a lower cutoff for overweight and obese categories compared to the World Health Organization (WHO) classification. The present study assessed patients with COPD among different BMI categories according to two BMI classification systems: WHO and Asia-Pacific. Patients and methods: Patients with COPD aged 40 years or older from the Korean COPD Subtype Study cohort were selected for evaluation. We enrolled 1,462 patients. Medical history including age, sex, St George’s Respiratory Questionnaire (SGRQ-C), the modified Medical Research Council (mMRC) dyspnea scale, and post-bronchodilator forced expiratory volume in 1 second (FEV1) were evaluated. Patients were categorized into different BMI groups according to the two BMI classification systems. Result: FEV1 and the diffusing capacity of the lung for carbon monoxide (DLCO) percentage revealed an inverse “U”-shaped pattern as the BMI groups changed from underweight to obese when WHO cutoffs were applied. When Asia-Pacific cutoffs were applied, FEV1 and DLCO (%) exhibited a linearly ascending relationship as the BMI increased, and the percentage of patients in the overweight and obese groups linearly decreased with increasing severity of the Global Initiative for Chronic Obstructive Lung Disease criteria. From the underweight to the overweight groups, SGRQ-C and mMRC had a decreasing relationship in both the WHO and Asia-Pacific classifications. The prevalence of comorbidities in the different BMI groups showed similar trends in both BMI classifications systems. Conclusion: The present study demonstrated that patients with COPD who have a high BMI have better pulmonary function and health-related quality of life and reduced dyspnea symptoms. Furthermore, the Asia-Pacific BMI classification more appropriately reflects the correlation of obesity and disease manifestation in Asian COPD patients than the WHO classification.Keywords
This publication has 55 references indexed in Scilit:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-AnalysisPLOS ONE, 2012
- Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel PhenotypePLOS ONE, 2012
- Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypesThorax, 2010
- Clinical COPD phenotypes: a novel approach using principal component and cluster analysesEuropean Respiratory Journal, 2010
- Predictors of Body Mass Index in Patients With Moderate to Severe EmphysemaCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2009
- Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adultsThe American Journal of Clinical Nutrition, 2009
- Obesity and the lung: 5 {middle dot} Obesity and COPDThorax, 2008
- Body-Mass Index and Mortality in Korean Men and WomenNew England Journal of Medicine, 2006
- Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patientsClinical Nutrition, 2005